Invus, a New York City-based investment business backed by Eric Wittouck, one of Belgium’s richest individuals, has invested in Cyclerion Therapeutics, a biotech group. Invus was one of seven investors committing $18 million to the Cambridge, Massachusetts-based group.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in
